Published on in Vol 23 , No 3 (2021) :March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/26799, first published .
Minimizing the Impact of the COVID-19 Epidemic on Oncology Clinical Trials: Retrospective Study of Beijing Cancer Hospital

Minimizing the Impact of the COVID-19 Epidemic on Oncology Clinical Trials: Retrospective Study of Beijing Cancer Hospital

Minimizing the Impact of the COVID-19 Epidemic on Oncology Clinical Trials: Retrospective Study of Beijing Cancer Hospital

Authors of this article:

Zhiying Fu 1 Author Orcid Image ;   Min Jiang 1 Author Orcid Image ;   Kun Wang 1 Author Orcid Image ;   Jian Li 1 Author Orcid Image

Journals

  1. Huret L, Stoeklé H, Benmaziane A, Beuzeboc P, Hervé C. Cancer and COVID-19: ethical issues concerning the use of telemedicine during the pandemic. BMC Health Services Research 2022;22(1) View
  2. Meghiref Y, Parnot C, Duverger C, Difoum F, Gourden A, Yssaad H, Leiterer C, Bedekovic C, Blanchard J, Nait Ammar H, Schernberg A, Vanquaethem H, Helissey C. The Use of Telemedicine in Cancer Clinical Trials: Connect-Patient-to-Doctor Prospective Study. JMIR Cancer 2022;8(1):e31255 View
  3. Audisio K, Lia H, Robinson N, Rahouma M, Soletti G, Cancelli G, Perezgrovas Olaria R, Chadow D, Tam D, Vervoort D, Farkouh M, Bhatt D, Fremes S, Gaudino M. Impact of the COVID-19 Pandemic on Non-COVID-19 Clinical Trials. Journal of Cardiovascular Development and Disease 2022;9(1):19 View